The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Ceramide-Rich Membrane Rafts Mediate CD40 Clustering
Abstract
Many receptor systems use receptor clustering for transmembrane signaling. In this study, we show that acid sphingomyelinase (ASM) is essential for the clustering of CD40. Stimulation of lymphocytes via CD40 ligation results in ASM translocation from intracellular stores, most likely vesicles, into distinct membrane domains on the extracellular surface of the plasma membrane. Surface ASM initiates a release of extracellularly oriented ceramide, which in turn mediates CD40 clustering in sphingolipid-rich membrane domains. ASM, ceramide, and CD40 colocalize in the cap-like structure of stimulated cells. Deficiency of ASM, destruction of sphingolipid-rich rafts, or neutralization of surface ceramide prevents CD40 clustering and CD40-initiated cell signaling. These findings indicate that the ASM-mediated release of ceramide and/or metabolites of ceramide regulate clustering of CD40, which seems to be a prerequisite for cellular activation via CD40.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FUNCTIONS OF LIPID RAFTS IN BIOLOGICAL MEMBRANES
Brown, D. A., & London, E. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.111 · Cited by 2,948
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Structure and Origin of Ordered Lipid Domains in Biological Membranes
Brown, D. A., & London, E. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900397 · Cited by 963
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
Aggregation of Lipid Rafts Accompanies Signaling via the T Cell Antigen Receptor
Janes, P. W., Ley, S. C., & Magee, A. I. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.447 · Cited by 796
Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., & Kroczek, R. A. (1993) · Nature · doi:10.1038/361539a0 · Cited by 721
CD95 Signaling via Ceramide-rich Membrane Rafts
Grassme, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., & Gulbins, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101207200 · Cited by 636
Self-citation
Cited by
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Płóciennikowska, A., Hromada-Judycka, A., Borzęcka, K., & Kwiatkowska, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1762-5 · Cited by 761
Radiation and ceramide-induced apoptosis
Kolesnick, R., & Fuks, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206702 · Cited by 506
Ceramide: second messenger or modulator of membrane structure and dynamics?
BLITTERSWIJK, W. J. V., LUIT, A. H. V. D., VELDMAN, R. J., VERHEIJ, M., & BORST, J. (2003) · Biochemical Journal · doi:10.1042/bj20021528 · Cited by 435
Raft ceramide in molecular medicine
Gulbins, E., & Kolesnick, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207146 · Cited by 422
Self-citationThe therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393
Ceramide: A simple sphingolipid with unique biophysical properties
Castro, B. M., Prieto, M., & Silva, L. C. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.01.004 · Cited by 382
Intracellular signal transduction pathways activated by ceramide and its metabolites
Ruvolo, P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 355
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Drobnik, W., Liebisch, G., Audebert, F.-X., Fröhlich, D., Glück, T., Vogel, P., Rothe, G., & Schmitz, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200401-jlr200 · Cited by 350
Cremesti, A. E., Goni, F. M., & Kolesnick, R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03489-0 · Cited by 342
Damage control: cellular mechanisms of plasma membrane repair
Andrews, N. W., Almeida, P. E., & Corrotte, M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.008 · Cited by 340
Acid and neutral sphingomyelinases: roles and mechanisms of regulation
Marchesini, N., & Hannun, Y. A. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-091 · Cited by 339
Ceramide-enriched membrane domains
Bollinger, C. R., Teichgräber, V., & Gulbins, E. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.09.001 · Cited by 325
Self-citationCisplatin-Induced CD95 Redistribution into Membrane Lipid Rafts of HT29 Human Colon Cancer Cells
Lacour, S., Hammann, A., Grazide, S., Lagadic-Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., & Dimanche-Boitrel, M.-T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2787 · Cited by 306
Ceramide‐rich platforms in transmembrane signaling
Stancevic, B., & Kolesnick, R. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.026 · Cited by 288
Ceramide-mediated clustering is required for CD95-DISC formation
Grassmé, H., Cremesti, A., Kolesnick, R., & Gulbins, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206540 · Cited by 271
Self-citationCeramide-enriched membrane domains—Structure and function
Zhang, Y., Li, X., Becker, K. A., & Gulbins, E. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.030 · Cited by 264
Self-citationLipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Self-citationRegulation of Lytic and Non-Lytic Functions of Gasdermin Pores
Rühl, S., & Broz, P. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167246 · Cited by 74
Metadata
- Authors
- Grassmé, H., Jendrossek, V., Bock, J., Riehle, A., & Gulbins, E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01-01
- Volume
- 168
- Issue
- 1
- Pages
- 298-307
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1678039705
- Cited by
- 261
- References
- 49
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.